Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Chem., 10 December 2025

Sec. Medicinal and Pharmaceutical Chemistry

Volume 13 - 2025 | https://doi.org/10.3389/fchem.2025.1748491

Correction: Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors

This article is a correction to:

  1. Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors

    1. Read original article
Lamya H. Al-WahaibiLamya H. Al-Wahaibi1Hesham A. Abou-ZiedHesham A. Abou-Zied2Martin NiegerMartin Nieger3Stefan Brse Stefan Bräse4*Bahaa G. M. Youssif Bahaa G. M. Youssif5*Hendawy N. Tawfeek,Hendawy N. Tawfeek6,7
  • 1Department of Chemistry, College of Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
  • 2Medicinal Chemistry Department, Faculty of Pharmacy, Deraya University, Minia, Egypt
  • 3Department of Chemistry, University of Helsinki, Helsinki, Finland
  • 4Institute of Biological and Chemical Systems, IBCS-FMS, Karlsruhe Institute of Technology, Karlsruhe, Germany
  • 5Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt
  • 6Chemistry Department, Faculty of Science, Minia University, El-Minia, Egypt
  • 7Unit of Occupational of Safety and Health, Administration Office of Minia University, El-Minia, Egypt

A Correction on
Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors

by Al-Wahaibi LH, Abou-Zied HA, Nieger M, Bräse S, Youssif BGM and Tawfeek HN (2025). Front. Chem. 13:1638489. doi: 10.3389/fchem.2025.1638489

An incorrect Funding statement was provided. The funding details were erroneously given in the Acknowledgments statement. The correct Funding statement reads:

The authors declare that financial support was received for the research and/or publication of this article. This work was funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project Number (PNURSP2025R3), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, and the KIT-Publication Fund of the Karlsruhe Institute of Technology.

The middle initial for author Hendawy N. Tawfeek was missing and this author’s surname was also misspelled as “Tawfik”.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: quinoline, kinases, X-ray, DFT, anticancer, EGFR, HER-2

Citation: Al-Wahaibi LH, Abou-Zied HA, Nieger M, Bräse S, Youssif BGM and Tawfeek HN (2025) Correction: Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors. Front. Chem. 13:1748491. doi: 10.3389/fchem.2025.1748491

Received: 17 November 2025; Accepted: 26 November 2025;
Published: 10 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Al-Wahaibi, Abou-Zied, Nieger, Bräse, Youssif and Tawfeek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bahaa G. M. Youssif, Ymd5b3Vzc2lmMkBnbWFpbC5jb20=; Stefan Bräse, YnJhZXNlQGtpdC5lZHU=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.